Cellular basis for improved left ventricular pump function after digoxin therapy in experimental left ventricular failure

Journal of the American College of Cardiology

Volumn 28, Issue 2, 1996, Pages 495-505

  McMahon, William S ^a   Holzgrefe, Henry ^b   Walker, Jennifer D ^a   Mukherjee, Rupak ^a   Arthur, Susan R ^a   Cavallo, Martyn J ^a   Child, Michael J ^b   Spinale, Francis G ^b,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGITOXIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFECT; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL;

EID: 0030220687     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00151-9     Document Type: Article

References (43)

1. 1. Withering W. An account of the foxglove and some of its medical uses, with practical remarks on dropsy, and other diseases. Birmingham, UK: M. Sweeney, 1785.
2. 2. Christian HA. Digitalis effects in chronic cardiac cases with regular rhythm in contrast to auricular fibrillation. Med Clin North Am 1922;5:1173-90.
3. 3. Kelly RA. Cardiac glycosides and congestive heart failure. Am J Cardiol 1990;65:10E-16E.
4. 4. Lee DC, Johnson RA, Bingham JB, et al. Heart failure in outpatients: a randomized trial of digoxin versus placebo. N Engl J Med 1982;306:699-705.
5. 5. Guyatt GH, Sullivan MJ, Fallen EL, et al. A controlled trial of digoxin in congestive heart failure. Am J Cardiol 1988;61:371-5.
6. 6. DiBianco R, Shabetai R, Kostuk W, Moran J, Schlant RC, Wright R, for the Milrinone Multicenter Trial Group. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med 1989;320:677-83.
7. 7. Packer M, Gheorghiade M, Young JB, et al., for the RADIANCE study. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. N Engl J Med 1993;329:1-7.
8. 8. Gheorghiade M, St. Clair J, St. Clair C, Beller GA. Hemodynamic effects of intravenous digoxin in patients with severe heart failure initially treated with diuretics and vasodilators. J Am Coll Cardiol 1987;9:849-57.
9. 9. Ribner HS, Plucinski DA, Hsieh AM, et al. Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: a hemodynamic-hormonal study. Am J Cardiol 1985;56: 896-904.
10. 10. Gheorghiade M, Ferguson D. Digoxin - a neurohormonal modulator in heart failure? Circulation 1991;84:2181-6.
11. 11. Dec WG. Evolving strategies for the outpatient management of advanced heart failure. ACC Curr J Rev 1995:57-60.
12. 12. Coleman HN, Taylor RR, Pool PE, et al. Congestive heart failure following chronic tachycardia. Am Heart J 1971;81:790-8.
13. 13. Kuchi K, Shannon RP, Komamura K, et al. Myocardial β-adrenergic receptor function during the development of pacing induced heart failure. J Clin Invest 1993;91:907-14.
14. 14. Roth DA, Kazushi U, Helmer GA, Hammond HK. Downregulation of cardiac guanosine 5′-triphosphate binding proteins in right and left ventricle in pacing induced congestive heart failure. J Clin Invest 1993;91:939-49.
15. 15. Spinale FG, Fulbright BM, Mukherjee R, et al. Relationship between ventricular and myocyte function with tachycardia induced cardiomyopathy. Circ Res 1992;71:174-87.
16. 16. Margulies KB, Heublein DM, Perrella MA, Burnett JC. ANF-mediated renal cGMP generation in congestive heart failure. Am J Physiol 1991;260: F562-F568.
17. 17. Spinale FG, Tempel GE, Mukherjee R, et al. Cellular and molecular changes in the β-adrenergic receptor system with supraventricular tachycardia induced cardiomyopathy. Cardiovasc Res 1994;28:1243-50.
18. 18. Lenfant C. Report of the task force on research in heart failure. Circulation 1994;90:1118-23.
19. 19. Hoffman BF, Bigger JT. Digitalis and allied cardiac glycosides. In: Gilman AG, Rall TW, Nies AS, Taylor P, editors. Goodman and Gilman's The Pharmacologic Basis of Therapeutics. 8th ed. Elmsford (NY): Pergamon Press, 1990:814-39.
20. 20. Spinale FG, Holzgrefe HH, Mukherjee R, et al. LV and myocyte structure and function after early recovery from tachycardia-induced cardiomyopathy. Am J Physiol 1995;268:H836-H847.
21. 21. Sabbah HN, Shimoyama H, Kono T, et al. Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction. Circulation 1994;89:2852-9.
22. 22. Laurenceau JL, Malergue MC. The Essentials in Echocardiography, M-Mode and 2-Dimensional Imaging. Norwell (MA): Martinus Nijhoff, 1981:64-70.
23. 23. Zile MR, Tanaka R, Lindroth JR, Spinale FG, Carabello BA, Mirsky I. Left ventricular volume determined echocardiographically by using a constant LV epicardial long axis to short axis dimension ratio throughout the cardiac cycle. J Am Coll Cardiol 1992;20:986-93.
24. 24. Tomita M, Spinale FG, Crawford FA, Zile MR. Changes in left ventricular volume, mass and function during development and regression of supraventricular tachycardia induced cardiomyopathy: disparity between recovery of systolic vs diastolic function. Circulation 1991;83:635-44.
25. 25. Goldstein DS, Feuerstein G, Izzo HL, Kopin IJ, Keiser H. Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci USA 1986;83:265-9.
26. +-ATPase in tachycardia induced cardiomyopathy. J Mol Cell Cardiol 1992;24:277-94.
27. 27. Mukherjee R, Hewett K, Crawford FA, Spinale FG. Relation between dynamic cellular and sarcomere contractile properties from the same cardiocyte. J Appl Physiol 1993;74:2023-33.
28. 28. Mukherjee R, Hewett KW, Spinale FG. Myocyte electrophysiological properties following the development of supraventricular tachycardia induced cardiomyopathy. J Mol Cell Cardiol 1995;27:1333-48.
29. 29. Steel RGD, Torrie JH. Principles and Procedures of Statistics: A Biometrical Approach. 2nd ed. New York: McGraw-Hill, 1980.
30. 30. Spinale FG, Holzgrefe HH, Mukherjee R, et al. Angiotensin converting enzyme inhibition and the progression of congestive cardiomyopathy: effects on left ventricular and myocyte structure and function. Circulation 1995;92: 562-78.
31. 31. Kelly RA, Smith TW. Digoxin in heart failure: implications of recent trials. J Am Coll Cardiol 1993;22:107A-112A.
32. 32. Captopril Digoxin Multicenter Research Group. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA 1988;259:539-44.
33. 33. Spinale FG, Zellner JL, Tomita M, Crawford FA, Zile MR. Relationship between ventricular and myocyte remodelling with the development and regression of supraventricular tachycardia induced cardiomyopathy. Circ Res 1991;69:1058-67.
34. 34. Kajstura J, Zhang Z, Liu Y, et al. The cellular basis of pacing induced dilated cardiomyopathy. Myocyte cell loss and myocyte cellular reactive hypertrophy. Circulation 1995;92:2306-17.
35. 1-receptor down regulation in heart failure. Circ Res 1986;59:297-309.
36. 36. Ferguson DW, Berg WJ, Sanders JS, Roach PJ, Kempf JS, Kienzle MG. Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Circulation 1989;80:65-77.
37. 37. Wang W, Chen J-S, Zucker IH. Carotid sinus baroreceptor sensitivity in experimental heart failure. Circulation 1990;81:1959-66.
38. 38. Katz AM. Physiology of the Heart. 2nd ed. New York: Raven Press, 1992.
39. 39. Eisner DA, Smith TW. The Na-K pump and its effectors in cardiac muscle. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, editors. The Heart and Cardiovascular System. 2nd ed. Raven Press: New York, 1992: 863-902.
40. 40. Cory CR, McCutcheon LJ, O'Grady M, Pang AW, Geiger JD, O'Brien PJ. Compensatory down regulation of myocardial Ca channel in sarcoplasmic reticulum from dogs with heart failure. Am J Physiol 1993;264:H926-H937.
41. 41. Woolf MR, Whitesell LF, Moss RL. Calcium sensitivity of isometric tension is increased in canine experimental heart failure. Circ Res 1995;76:781-9.
42. 42. Zile MR, Mukherjee R, Clayton C, Kato S, Spinale FG. Effects of chronic supraventricular pacing tachycardia on relaxation rate in isolated cardiac muscle cells. Am J Physiol 1995;268:H2104-H2113.
43. +-ATPase) concentration in human heart left ventricle samples obtained at necropsy after long term digitalisation. Cardiovasc Res 1991;25:684-91.